The North America Clinical Trial Supply & Logistics Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028).
The development of digital technology enabled the surmounting of the obstacles that arose during clinical trials, and future clinical trials will require the same. Some digital services, such as cloud-enabled digital core, blockchain-based product tracking, use of the internet of things, etc., are likely to transform biopharmaceutical companies' approach to clinical supplies management by incorporating valuable insight from multiple data sources, improving patient experience, boosting clinical trial productivity, and enhancing the quality of data collected during trials.
In June 2020, for instance, Almac Clinical Technologies, a subsidiary of the Almac Group, unveiled Simplify, an IRT solution of the next generation. It has a standard set of adjustable features to speed up the study initiation procedure.
Due to the increasing number of clinical trials, North America's clinical trial supply and logistics market were the largest in the world. In North America, the industry is driven by technology improvements, government financing, and the rising incidence of diseases. Due to a more significant number of large-scale pharma R&D clinical trials undertaken in this region, the regional headquarters of significant CROs and biopharmaceutical companies are located in this region. In addition, North America is the largest market for clinical trial supply & logistics. The most effective regulation of clinical trials with advanced therapies like electronic records and signatures, protection of human subjects, and good clinical practices for non-clinical laboratory studies facilitate the overall clinical trial studies. The clinical trial supply & logistics market in North America has the greatest market size and is anticipated to experience substantial expansion during the forecast period.
The US market dominated the North America Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,488.9 Million by 2028.The Canada market is poised to grow at a CAGR of 9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
The development of digital technology enabled the surmounting of the obstacles that arose during clinical trials, and future clinical trials will require the same. Some digital services, such as cloud-enabled digital core, blockchain-based product tracking, use of the internet of things, etc., are likely to transform biopharmaceutical companies' approach to clinical supplies management by incorporating valuable insight from multiple data sources, improving patient experience, boosting clinical trial productivity, and enhancing the quality of data collected during trials.
In June 2020, for instance, Almac Clinical Technologies, a subsidiary of the Almac Group, unveiled Simplify, an IRT solution of the next generation. It has a standard set of adjustable features to speed up the study initiation procedure.
Due to the increasing number of clinical trials, North America's clinical trial supply and logistics market were the largest in the world. In North America, the industry is driven by technology improvements, government financing, and the rising incidence of diseases. Due to a more significant number of large-scale pharma R&D clinical trials undertaken in this region, the regional headquarters of significant CROs and biopharmaceutical companies are located in this region. In addition, North America is the largest market for clinical trial supply & logistics. The most effective regulation of clinical trials with advanced therapies like electronic records and signatures, protection of human subjects, and good clinical practices for non-clinical laboratory studies facilitate the overall clinical trial studies. The clinical trial supply & logistics market in North America has the greatest market size and is anticipated to experience substantial expansion during the forecast period.
The US market dominated the North America Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,488.9 Million by 2028.The Canada market is poised to grow at a CAGR of 9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
Scope of the Study
Market Segments Covered in the Report:
By End-user
- Pharmaceuticals
- Biologicals
- Medical Device
By Therapeutic Area
- Cardiovascular Diseases
- Respiratory Diseases
- CNS & Mental Disorders
- Oncology
- Others
By Phase
- Phase III
- Phase II
- Phase I
- Phase IV
By Service
- Logistics & Distribution
- Comparator Sourcing
- Storage & Retention
- Packaging, Labeling, & Blinding
- Manufacturing
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc
- Catalent, Inc
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Trial Supply & Logistics Market, by End-user
1.4.2 North America Clinical Trial Supply & Logistics Market, by Therapeutic Area
1.4.3 North America Clinical Trial Supply & Logistics Market, by Phase
1.4.4 North America Clinical Trial Supply & Logistics Market, by Service
1.4.5 North America Clinical Trial Supply & Logistics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Scenario and Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Clinical Trial Supply & Logistics Market
Chapter 4. North America Clinical Trial Supply & Logistics Market by End-user
4.1 North America Pharmaceuticals Market by Country
4.2 North America Biologicals Market by Country
4.3 North America Medical Device Market by Country
Chapter 5. North America Clinical Trial Supply & Logistics Market by Therapeutic Area
5.1 North America Cardiovascular Diseases Market by Country
5.2 North America Respiratory Diseases Market by Country
5.3 North America CNS & Mental Disorders Market by Country
5.4 North America Oncology Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Clinical Trial Supply & Logistics Market by Phase
6.1 North America Phase III Market by Country
6.2 North America Phase II Market by Country
6.3 North America Phase I Market by Country
6.4 North America Phase IV Market by Country
Chapter 7. North America Clinical Trial Supply & Logistics Market by Service
7.1 North America Logistics & Distribution Market by Country
7.2 North America Comparator Sourcing Market by Country
7.3 North America Storage & Retention Market by Country
7.4 North America Packaging, Labeling, & Blinding Market by Country
7.5 North America Manufacturing Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Clinical Trial Supply & Logistics Market by Country
8.1 US Clinical Trial Supply & Logistics Market
8.1.1 US Clinical Trial Supply & Logistics Market by End-user
8.1.2 US Clinical Trial Supply & Logistics Market by Therapeutic Area
8.1.3 US Clinical Trial Supply & Logistics Market by Phase
8.1.4 US Clinical Trial Supply & Logistics Market by Service
8.2 Canada Clinical Trial Supply & Logistics Market
8.2.1 Canada Clinical Trial Supply & Logistics Market by End-user
8.2.2 Canada Clinical Trial Supply & Logistics Market by Therapeutic Area
8.2.3 Canada Clinical Trial Supply & Logistics Market by Phase
8.2.4 Canada Clinical Trial Supply & Logistics Market by Service
8.3 Mexico Clinical Trial Supply & Logistics Market
8.3.1 Mexico Clinical Trial Supply & Logistics Market by End-user
8.3.2 Mexico Clinical Trial Supply & Logistics Market by Therapeutic Area
8.3.3 Mexico Clinical Trial Supply & Logistics Market by Phase
8.3.4 Mexico Clinical Trial Supply & Logistics Market by Service
8.4 Rest of North America Clinical Trial Supply & Logistics Market
8.4.1 Rest of North America Clinical Trial Supply & Logistics Market by End-user
8.4.2 Rest of North America Clinical Trial Supply & Logistics Market by Therapeutic Area
8.4.3 Rest of North America Clinical Trial Supply & Logistics Market by Phase
8.4.4 Rest of North America Clinical Trial Supply & Logistics Market by Service
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc. (Pantheon)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Catalent, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.3 Marken (United Parcel Service of America, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.4 Piramal Enterprises Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent strategies and developments:
9.4.4.1 Product Launches and Product Expansions:
9.5 Deutsche Post DHL Group (The Deutsche Post AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Acquisition and Mergers:
9.6 FedEx Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.7 Inizio Group Limited (Clayton, Dubilier & Rice)
9.7.1 Company Overview
9.8 Parexel International Corporation (Phoenix Parentco, Inc.)
9.8.1 Company Overview
9.9 Almac Group
9.9.1 Company Overview
9.10. Movianto (Walden Group SAS)
9.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Catalent, Inc.
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Methodology
LOADING...
